Thursday, January 23, 2025

Healthcare

Advancing Neurological Solutions with Game-Changing Science

Bright Minds Biosciences Inc. (NASDAQ: DRUG) is a biotechnology company focused on developing novel therapies for neurological and neuropsychiatric disorders, such as healing the central nervous...

Investing in Biotech: Why 2024 Could Be the Year of Major Gains

2024 sees a biotech rebound, with over 15 IPOs by mid-year and capital inflows increasing across the sector. Gene therapy and oncology are driving biotech...

Bright Minds Targets Epilepsy with Breakthrough 5-HT2C Agonist

Bright Minds Biosciences launches a Phase 2 trial for BMB-101, targeting drug-resistant epilepsy with high unmet needs. The company trades at a $5M market cap,...

A Closer Look at NurExone: Exosome Innovation with Long-Term Potential (TSXV: NRX, OTCQB: NRXBF)

NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company developing regenerative medicine therapies. NurExone chose to base its...

CULT Food Science is Pioneering a New Era of Food Tech

CULT Food Science Corp. ("CULT" or the "Company") (CSE: CULT) (OTC: CULTF) (FRA: LN0) is a disruptive food technology platform pioneering the commercialization of lab-grown meat and...

Popular

Subscribe